相关实验视频

Updated: Jun 26, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

在可切割的NSCLC中,新辅助和辅助免疫疗法

Evangelia Bogatsa¹, George Lazaridis¹, Chrysoula Stivanaki¹

¹Department of Medical Oncology, Aristotle University of Thessaloniki, Papageorgiou Hospital, 56429 Thessaloniki, Greece.

|May 11, 2024

概括

早期非小细胞肺癌 (NSCLC) 治疗正在使用免疫检查点抑制剂 (ICI) 发展. 研究重点是优化ICI疗法和识别生物标志物,以获得可切除NSCLC的更好的结果.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
胸部外科手术胸部外科手术

背景情况:

早期非小细胞肺癌 (NSCLC) 存在挑战,尽管有进展,但生存率和复发率不佳.
基于免疫的疗法的整合,反映了高级NSCLC的策略,正在改变早期阶段的管理.
免疫检查点抑制剂 (ICI) 正在研究可切除NSCLC的新辅助,辅助和外科设置.

研究的目的:

审查目前针对早期NSCLC的免疫疗法治疗选择.
分析各种ICI制度的优缺点.
讨论针对可切除NSCLC的免疫疗法的持续挑战和未来方向.

主要方法:

对临床试验和ICI在早期NSCLC中的研究的综合文献综述.
分析治疗策略,包括单疗法,组合疗法和术后治疗方法.
对预测治疗反应的生物标志物研究的评估.

主要成果:

ICI疗法在早期NSCLC的新辅助,辅助和外科手术环境中表现有前途.
目前正在进行的研究旨在针对特定患者子组个性化ICI治疗.
生物标志物识别对于预测反应和提高生存率至关重要.

结论:

免疫疗法,特别是ICI,在切除性NSCLC的治疗方面取得了重大进展.
优化治疗策略和识别预测生物标志物是最大化患者益处的关键.
未来的研究有可能进一步完善免疫疗法方法,开启肺癌早期治疗的新时代.

关键词:

一个辅助的辅助者.早期早期早期早期免疫检查点抑制剂免疫检查点抑制剂免疫疗法免疫疗法这是一种新辅助剂.非小细胞肺癌的肺癌.在外科手术期间的外科手术.可切除的可切除物

更多相关视频

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...